1H NMR analysis of choline metabolites in fine-needle-aspirate biopsies of breast cancer

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 26, Issue 3, 2013, Pages 337-343

  Pearce, John M ^a,b   Mahoney, Mary C ^a   Lee, Jing Huei ^a   Chu, Wen Jang ^a   Cecil, Kim M ^a,b   Strakowski, Stephen M ^a   Komoroski, Richard A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Biopsy; Glycerophosphocholine; Lidocaine; Phosphocholine; Phosphoethanolamine

Indexed keywords

CHOLINE; PROTON; TUMOR MARKER;

BREAST TUMOR; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC USE; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; METABOLISM; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; CHOLINE; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84891675635     PISSN: 09685243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10334-012-0349-0     Document Type: Article

References (33)

1. Podo F (1999) Tumour phospholipid metabolism. NMR Biomed 12:413-439
2. Podo F, Canevari S, Canese R, Pisanu ME, Ricci A, Iorio E (2011) MR evaluation of response to targeted treatment in cancer cells. NMR Biomed 24:648-672
3. Glunde K, Bhujwalla ZM, Ronen SM (2011) Choline metabolism in malignant transformation. Nat Rev Cancer 11:835-848
4. Aboagye EO, Bhujwalla ZM (1999) Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 59:80-84
5. Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS (2006) Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 19:30-40
6. Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H (2002) Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res 62:1966-1970
7. Glunde K, Jie C, Bhujwalla ZM (2004) Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res 64:4270-4276
8. Glunde K, Ackerstaff E, Mori N, Jacobs MA, Bhujwalla ZM (2006) Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. Mol Pharmaceutics 3:496-506
9. Morse DL, Carroll D, Day S, Gray H, Sadarangani P, Murthi S, Job C, Baggert B, Raghunand N, Gillies RJ (2009) Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway. NMR Biomed 22:114-127
10. Podo F, Sardanelli F, Iorio E, Canese R, Carpinelli G, Fausto A, Canevari S (2007) Abnormal choline phospholipid metabolism in breast and ovary cancer: molecular bases for noninvasive imaging approaches. Curr Med Imaging Rev 3:123-137
11. Eliyahu G, Kreizman T, Degani H (2007) Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int J Cancer 120:1721-1730
12. Mountford C, Lean C, Malycha P, Russell P (2006) Proton spectroscopy provides accurate pathology on biopsy and in vivo. J Magn Reson Imaging 24:459-477
13. Haddadin IS, McIntosh A, Meisamy S, Corum C, Styczynski Snyder AL, Powell NJ, Nelson MT, Yee D, Garwood M, Bolan PJ (2009) Metabolite quantification and high-field MRS in breast cancer. NMR Biomed 22:65-76
14. Sharma U, Jagannathan NR (2009) Biochemical characterization of breast tumors by in vivo and in vitro magnetic resonance spectroscopy (MRS). Biophys Rev 1:21-26
15. 1H MRS at 7 T: initial results in human breast cancer. NMR Biomed 24:1337-1342
16. Gribbestad IS, Sitter B, Lundgren S, Krane J, Axelson D (1999) Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 19:1737-1746
17. 1H NMR metabonomics to breast cancer characterization and detection. Prog NMR Spectrosc 47:165-174
18. Kumar M, Seenu V, Julka PK, Srivastava A, Kapila K, Rath GK, Jagannathan NR (2005) Proton MR spectroscopy of human breast cancer. In: Jagannathan NR (ed) Recent advances in mr imaging and spectroscopy. Jaypee Bros, New Delhi, pp 312-344
19. Sitter B, Bathen TF, Tessem M-B, Gribbestad IS (2009) High-resolution magic angle spinning (HR-MAS) MR spectroscopy in metabolic characterization of human cancer. Prog NMR Spectrosc 54:239-254
20. Beckonert O, Coen M, Keun HC, Wang Y, Ebbels TMD, Holmes E, Lindon JC, Nicholson JK (2010) High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nature Prot 5:1019-1032
21. Sitter B, Bathen TF, Singstad TE, Fjosne HE, Lundgren S, Halgunset J, Gribbestad IS (2010) Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR Biomed 23:424-431
22. Mackinnon WB, Barry PA, Malycha PL, Gillett DJ, Russell P, Lean CL, Doran ST, Barraclough BH, Bilous M, Mountford CE (1997) Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 204:661-666
23. Mountford CE, Somorjai RL, Malycha P, Gluch L, Lean C, Russell P, Barraclough B, Gillett D, Himmelreich U, Dolenko B, Nikulin AE, Smith ICP (2001) Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br J Surg 88:1234-1240
24. Lean C, Doran S, Somorjai RL, Malycha P, Clarke D, Himmelreich U, Bourne R, Dolenko R, Nikulin AE, Mountford C (2004) Determination of grade and receptor status from the primary breast lesion by magnetic resonance spectroscopy. Technol Cancer Res Treat 3:551-556
25. Bourne R, Dzendrowskyj T, Mountford C (2003) Leakage of metabolites from tissue biopsies can result in large errors in quantitation by MRS. NMR Biomed 16:96-101
26. 31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain. Magn Reson Med 59:469-474
27. 1H magnetic resonance spectroscopy at 7 T. Magn Reson Med 67:20-26
28. 31P NMR spectra from human breast tumours: variations in phospholipid metabolism. Br J Cancer 63:514-516
29. van Asten JJA, Cuijpers V, Hulsbergen-van de Kaa C, Soede-Huijbregts C, Witjes JA, Verhofstad A, Heerschap A (2008) High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies. Magn Reson Mater Phy 21:435-442
30. Santos CF, Kurhanewicz J, Tabatabai ZL, Simko JP, Keshari KR, Gbegnon A, Delos Santos R, Federman S, Shinohara K, Carroll PR, Haqq CM, Swanson MG (2010) Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy. NMR Biomed 23:391-398
31. Schenetti L, Mucci A, Parenti F, Cagnoli R, Righi V, Tosi MR, Tugnoli V (2006) HR-MAS NMR spectroscopy in the characterization of human tissues: application to healthy gastric mucosa. Concepts Magn Reson 28A:430-443
32. Moestue SA, Borgan E, Huuse EM, Lindholm EM, Sitter B, Børresen-Dale A-L, Engebraaten O, Mælandsmo GM, Gribbestad IS (2010) Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models. BMC Cancer 10:433-445
33. Mahoney MC, Lee JH, Chu WJ, Pearce JM, Cecil KM, Strakowski SM, Komoroski RA (2010) Choline metabolite ratios from NMR as markers of human breast cancer. In: Proceedings of the 18th scientific meeting, International Society for Magnetic Resonance in Medicine, Stockholm, p 2765